Two-Year Outcomes for Patients with Non-ST-Elevation Acute Coronary Syndrome Treated with Magmaris and Absorb Bioresorbable Scaffolds in Large-Vessel Lesions.
Adrian WłodarczakPiotr RolaSzymon WłodarczakMarek SzudrowiczKatarzyna GiniewiczMagdalena ŁanochaJoanna Jaroszewska-PozorskaMateusz BaryckiŁukasz FurtanMichalina KędzierskaPiotr WłodarczakAdrian DoroszkoMaciej LesiakPublished in: Journal of personalized medicine (2024)
Magmaris demonstrated a good safety profile and more favorable clinical outcomes when compared to Absorb in patients with non-ST-elevation ACS.